{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:22:21Z","timestamp":1792736541828,"version":"4.5.0"},"reference-count":20,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2002,1,5]],"date-time":"2002-01-05T00:00:00Z","timestamp":1010188800000},"content-version":"vor","delay-in-days":1161,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[1998,11]]},"abstract":"<jats:sec><jats:label\/><jats:p> <jats:bold>Abstract.<\/jats:bold> Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD (Rabin Medical Center, Petah\u2010Tiqva, and Tel\u2010Aviv University, Tel\u2010Aviv, Israel). The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. <jats:italic>J Intern Med<\/jats:italic> 1998; <jats:bold>244<\/jats:bold>: 379\u201386.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To test whether empirical antibiotic treatment that matches the <jats:italic>in vitro<\/jats:italic> susceptibility of the pathogen (appropriate treatment) improves survival in patients with bloodstream infections; and to measure the improvement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Observational, prospective cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>University hospital in Israel.<\/jats:p><\/jats:sec><jats:sec><jats:title>Subjects<\/jats:title><jats:p>All patients with bloodstream infections detected during 1988\u201394.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>None.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>In\u2010hospital fatality rate and length of hospitalization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of 2158 patients given appropriate empirical antibiotic treatment, 436 (20%) died, compared with 432 of 1255 patients (34%) given inappropriate treatment (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.0001). The median durations of hospital stay for patients who survived were 9\u00a0days for patients given appropriate treatment and 11\u00a0days for patients given inappropriate treatment. For patients who died, the median durations were 5 and 4\u00a0days, respectively (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05), for both comparisons.<\/jats:p><jats:p>In a stratified analysis, fatality was higher in patients given inappropriate treatment than in those given appropriate treatment in all strata but two: patients with infections caused by streptococci other than <jats:italic>Streptococcus gr.\u00a0A<\/jats:italic> and <jats:italic>Streptoccocus pneumoniae<\/jats:italic> (odds ratio (OR) of 1.0, 95% confidence interval (95%\u00a0CI) 0.4\u20132.5); and hypothermic patients (OR\u00a0=\u00a00.9, 95%\u00a0CI\u00a0=\u00a00.3\u20132.4). Even in patients with septic shock, inappropriate empirical treatment was associated with higher fatality rate (OR\u00a0=\u00a01.6, 95%\u00a0CI\u00a0=\u00a01.0\u20132.7). The highest benefit associated with appropriate treatment was observed in paediatric patients (OR = 5.1, 95% CI = 2.4\u2013 10.7); intra\u2010abdominal infections (OR\u00a0=\u00a03.8, 95% CI = 2.0\u20137.1); infections of the skin and soft tissues (OR = 3.1, 95% CI\u00a0=\u00a01.8\u20135.6); and infections caused by <jats:italic>Klebsiella pneumoniae<\/jats:italic> (OR\u00a0=\u00a03.0, 95%\u00a0 CI = 1.7\u20135.1) and <jats:italic>S. pneumoniae<\/jats:italic> (OR\u00a0=\u00a02.6, 95%\u00a0 C = 1.1\u20135.9).<\/jats:p><jats:p>On a multivariable logistic regression analysis, the contribution of inappropriate empirical treatment to fatality was independent of other risk factors (multivariable adjusted OR\u00a0=\u00a01.6, 95%\u00a0CI\u00a0=\u00a01.3\u20131.9).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Appropriate empirical antibiotic treatment was associated with a significant reduction in fatality in patients with bloodstream infection.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2796.1998.00379.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:08:20Z","timestamp":1047449300000},"page":"379-386","source":"Crossref","is-referenced-by-count":547,"title":["The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection"],"prefix":"10.1111","volume":"244","author":[{"family":"Leibovici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Drucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Konigsberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Samra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Pitlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Pitlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,5]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.4.629"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.1.54"},{"key":"e_1_2_5_4_2","first-page":"427","article-title":"An analysis of community and hospital\u2010acquired bacteraemia in a large teaching hospital in the United Kingdom.","volume":"63","author":"Ispahani P","year":"1987","journal-title":"Q J Med"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/19.2.246"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/archinte.1995.00430110089009","article-title":"Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths.","volume":"155","author":"Pittet D","year":"1995","journal-title":"Arch Intern Med"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.1995.03530100047033","article-title":"Long\u2010term survival following bacteremia or fungemia.","volume":"274","author":"Leibovici L","year":"1995","journal-title":"JAMA"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/89.7.515"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.1996.03530270029027","article-title":"Trends in infectious diseases mortality in the United States.","volume":"275","author":"Pinner RW","year":"1996","journal-title":"JAMA"},{"key":"e_1_2_5_10_2","first-page":"1701","article-title":"Pharmacy\u2010based antimicrobial\u2010monitoring service.","volume":"49","author":"Berman JR","year":"1992","journal-title":"Am J Hosp Pharm"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-10-199605150-00004"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404283301725"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-4-199508150-00002"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90694-7"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90333-1"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.6.1008"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/archinte.1985.00360070082014","article-title":"Improved mortality in gram\u2010negative bacillary bacteremia.","volume":"145","author":"McCue JD","year":"1985","journal-title":"Arch Intern Med"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549109075086"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00946.x"},{"key":"e_1_2_5_20_2","unstructured":"J Infect Dis1991;163: 951\u20138."},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/18.Supplement_C.255"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2796.1998.00379.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.1998.00379.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2796.1998.00379.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.1998.00379.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:09:09Z","timestamp":1694419749000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2796.1998.00379.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["10.1046\/j.1365-2796.1998.00379.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2796.1998.00379.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}